Thrilled to welcome this outstanding group of trailblazers to the BWH Cardiology family, we are so excited!! 🤩🤩🤩

“Stay small enough long enough, you’ll be big enough soon enough” ~ Proctor

Never underestimate someone’s 3 months of experience ahead of you—let alone a full year.

Amit Goyal MD MAS CardioNerds Rachel Goodman Tommy Das, MD Daniel Ambinder, MD Yiannis Chatzizisis

It’s time to bring back the tradition of clapping after a safe landing. 🛬👏🏾👏🏾

Dr. Rhonda Sealey-Thomas joins us today at #CUGH2025 in #Atlanta.🎙️ Don't miss her keynote, "What the Global Health Community Can Do to Improve Public Health Outcomes Across the Americas Given the Rise in NCD's". Get ready to be inspired!

Can’t wait to get started with this amazing crew Diana De Oliveira Gomes, MD Christian Faaborg Andersen MD Bõna Dzekem, MD Ramael Ohiomoba! Missing Matthew Alsaloum, Aileen and Mike! Thank you, Chiefs Brigham & Women's CV Fellows!

Sinner may be the better player but Alcaraz is entertaining #RolandGarros #frenchopen2025

Alcaraz has played of of the finest games I’ve ever seen

Very hard to explain

Just out in European Society of Cardiology Journals we (Adam Cifu + Jonathan Paul) review endovascular therapy in intermediate-risk PE. Link: doi.org/10.1093/ehjope…

Powerful review

Big news in pulmonary embolism care: University of Chicago Medicine has been named a Comprehensive Pulmonary Embolism Center of Excellence by The PERT Consortium®. 🔹 1 of only 6 centers in the U.S. 🔹 The first and only in the Midwest Led by Jonathan Paul, MD (Jonathan Paul),

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure: NEJM @ESCCongress 🥸 Is evidence still in favor of beta blockers post AMI? #ESCCongress2025 😱Summary 👇👇👇

Congratulations to Brian Bergmark of #MGBInterventionalCardiology for his presentation at ESC2025 of ESSENCE TIMI73b and simultaneous NEJM publication. His second first author NEJM paper (2 more than me for those counting). More to come from this IC/trialist star!

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction: NEJM 🥸 Will the use of Aspirin decline overtime in ACS management? #ESCCongress2025 😱The TARGET-FIRST trial 👇👇👇

Tylenol 🤔